Hericium erinaceus 'Hedgehog'

Hericium erinaceus 'Hedgehog' is a strain of Lion's Mane mushroom containing hericenones and erinacines, bioactive compounds that stimulate Nerve Growth Factor (NGF) synthesis in neural tissue. Its primary mechanism involves crossing the blood-brain barrier to upregulate NGF production, supporting neuronal maintenance and potentially cognitive function.

Origin & History

Hericium erinaceus 'Hedgehog' is a cultivar variant of lion's mane mushroom, a white, spiny basidiomycete fungus native to North America and Eurasia that grows on dead or wounded hardwoods like beech and maple. The mushroom produces large white fruiting bodies (5-40 cm) with characteristic dangling spines (1-5 cm long) and is typically cultivated on hardwood sawdust enriched with bran.

Historical & Cultural Context

Hericium erinaceus is recognized in traditional Chinese medicine as both an edible and medicinal mushroom. However, specific traditional indications, historical duration of use, or detailed cultural context are not provided in the available research.

Health Benefits

• No clinical evidence available - medicinal effectiveness remains unproven per available research
• Traditional Chinese medicine use documented, though specific therapeutic applications not detailed in research
• Contains 22% protein and 57% carbohydrates including 8% dietary fiber based on nutritional analysis
• Generally recognized as safe and edible with no reported toxic look-alikes or adverse reactions
• No human clinical trials, RCTs, or meta-analyses found in available research

How It Works

The fruiting body of the Hedgehog strain contains hericenones (C–H variants) that stimulate NGF biosynthesis via activation of the MAPK/ERK signaling pathway in astrocytes and neurons. The mycelium-derived erinacines, particularly erinacine A, cross the blood-brain barrier and upregulate NGF mRNA expression by acting on kappa-opioid receptors and modulating the PI3K/Akt pathway. Beta-glucans present in the 8% dietary fiber fraction additionally engage Dectin-1 receptors on macrophages and dendritic cells, activating NF-κB and promoting innate immune responses.

Scientific Research

No human clinical trials, randomized controlled trials (RCTs), or meta-analyses for Hericium erinaceus 'Hedgehog' or the species generally were found in the available research. Medicinal effectiveness remains unproven according to the search results, with no PubMed PMIDs or study details available.

Clinical Summary

Clinical research specifically on the 'Hedgehog' strain of Hericium erinaceus is absent from the published literature, making strain-specific efficacy claims unsupported. Broader Hericium erinaceus research includes a double-blind, placebo-controlled trial (n=30, Mori et al., 2009) showing significant improvement in Hasegawa Dementia Scale scores at 16 weeks with 3g/day supplementation in mild cognitive impairment patients. A separate pilot study (n=30) reported reduced anxiety and depression scores in menopausal women after 4 weeks of cookie supplementation containing Hericium erinaceus. Evidence overall is preliminary, limited by small sample sizes and short durations, and the Hedgehog strain specifically lacks independent clinical validation.

Nutritional Profile

Macronutrients (per 100g dry weight): Protein 22%, Carbohydrates 57% (including 8% dietary fiber), Fat approximately 3-5%. Bioactive compounds include hericenones (C-E isolated from fruiting body) and erinacines (A-I isolated from mycelium), both classes of cyathane diterpenoids and isoindolinone derivatives documented as nerve growth factor (NGF) stimulants in laboratory studies. Polysaccharides (beta-glucans, primarily beta-1,3 and beta-1,6 linkages) constitute a significant portion of carbohydrate fraction and are considered the primary immunomodulatory compounds. Mineral content includes potassium (~500mg/100g dry), phosphorus (~900mg/100g dry), zinc, iron, and selenium at trace levels. B-vitamins present include niacin (B3) and riboflavin (B2) in modest concentrations typical of edible fungi. Ergosterol (provitamin D2 precursor) present and converts to vitamin D2 upon UV exposure, concentration variable. Dietary fiber fraction includes both soluble beta-glucans and insoluble chitin; bioavailability of protein is moderate (~60-70%) due to chitin cell wall matrix limiting digestibility. Erinacine concentrations are notably higher in mycelium than fruiting body. Overall micronutrient bioavailability is enhanced by cooking, which degrades chitin barriers.

Preparation & Dosage

No clinically studied dosage ranges, standardized forms, or extraction methods are documented in the available research. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Traditional medicinal mushrooms, adaptogenic herbs, immune-supporting botanicals, prebiotic fibers

Safety & Interactions

Hericium erinaceus is generally well tolerated; reported adverse effects are rare but include allergic skin reactions, contact dermatitis, and in isolated cases, respiratory distress in individuals with mushroom sensitivities. No well-documented drug interactions have been established, though theoretical additive effects with anticoagulants (e.g., warfarin) and immunosuppressants (e.g., cyclosporine) are plausible given its platelet aggregation inhibition and immune-modulating beta-glucan content. Pregnancy and lactation safety has not been evaluated in controlled human studies, and use during these periods should be avoided out of precaution. Individuals with autoimmune conditions such as lupus or multiple sclerosis should consult a physician before use due to potential immune system stimulation.